Article
Inactivation of the miltefosine transporter, LdMT, causes miltefosine resistance that is conferred to the amastigote stage of Leishmania donovani and persists in vivo.
International journal of antimicrobial agents - 1 Sept 2007
Seifert Karin, Pérez-Victoria F Javier, Stettler Marianne, Sánchez-Cañete María P, Castanys Santiago, Gamarro Francisco, Croft Simon L
Abstract excerpt
Miltefosine (hexadecylphosphocholine) is the first oral antileishmanial drug. In this study, we addressed the question whether miltefosine-resistant Leishmania donovani promastigotes transform to miltefosine-resistant amastigotes. A promastigote line, M-mutR, showed defective internalisation of m...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
